Metraipolis › archive › dc_e87bb5a0af01
Enhanced enfortumab vedotin sensitivity in a cisplatin-resistant bladder cancer model — Europe PMC PMID:42955934
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42955934
- DOI
- 10.1371/journal.pone.0361593
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T21:56:39.020Z
- SHA-256 of the archived text
22c6862b9206b4bcff577ebdf3a4b6d741896f69579665c2fe7703a0966f4382- Stable URL of this page
https://metraipolis.com/documento/dc_e87bb5a0af01
How to cite
Enhanced enfortumab vedotin sensitivity in a cisplatin-resistant bladder cancer model — Europe PMC PMID:42955934 — Europe PMC (en), https://europepmc.org/article/MED/42955934 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e87bb5a0af01 (Metraipolis archive dc_e87bb5a0af01, sha256 22c6862b9206b4bcff577ebdf3a4b6d741896f69579665c2fe7703a0966f4382)
BibTeX
@misc{dce87bb5a0af01,
title = {Enhanced enfortumab vedotin sensitivity in a cisplatin-resistant bladder cancer model — Europe PMC PMID:42955934},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42955934},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e87bb5a0af01; sha256 22c6862b9206b4bcff577ebdf3a4b6d741896f69579665c2fe7703a0966f4382},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42955934. Agents can read the archived copy with the MCP tool read_document.